Cargando…

Impact of a Patient’s Baseline Risk on the Relative Benefit and Harm of a Preventive Treatment Strategy: Applying Trial Results in Clinical Decision Making

BACKGROUND: For translating an overall trial result into an individual patient’s expected absolute treatment effect, differences in relative treatment effect between patients need to be taken into account. The aim of this study was to evaluate whether relative treatment effects of medication in 2 la...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Vries, Tamar I., Stam‐Slob, Manon C., Peters, Ron J. G., van der Graaf, Yolanda, Westerink, Jan, Visseren, Frank L. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075204/ https://www.ncbi.nlm.nih.gov/pubmed/34935407 http://dx.doi.org/10.1161/JAHA.120.017605

Ejemplares similares

Cost‐Effectiveness of Intensifying Lipid‐Lowering Therapy With Statins Based on Individual Absolute Benefit in Coronary Artery Disease Patients
por: Stam‐Slob, Manon C., et al.
Publicado: (2017)

Personalized absolute benefit of statin treatment for primary or secondary prevention of vascular disease in individual elderly patients
por: Stam-Slob, Manon C., et al.
Publicado: (2016)

The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular disease
por: Bots, Sophie H., et al.
Publicado: (2016)

Development of a clinical decision tool to reduce diagnostic testing for primary aldosteronism in patients with difficult-to-control hypertension
por: van Kleef, Monique E. A. M., et al.
Publicado: (2020)

Would treatment decisions about secondary prevention of CVD based on estimated lifetime benefit rather than 10-year risk reduction be cost-effective?
por: Berkelmans, Gijs F. N., et al.
Publicado: (2020)

Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials
por: de Jong, Marit, et al.
Publicado: (2017)

Core harm outcome sets developed by drug are needed to allow informed risk-benefit decision making
por: Cornelius, Victoria, et al.
Publicado: (2015)

Effect of information about the benefits and harms of mammography on women’s decision making: The InforMa randomised controlled trial
por: Pérez-Lacasta, María José, et al.
Publicado: (2019)

Mediation analysis of the relationship between type 2 diabetes and cardiovascular events and all‐cause mortality: Findings from the SMART cohort
por: Sharif, Shahnam, et al.
Publicado: (2019)

Relationship between classic vascular risk factors and cumulative recurrent cardiovascular event burden in patients with clinically manifest vascular disease: results from the UCC-SMART prospective cohort study
por: de Vries, Tamar Irene, et al.
Publicado: (2021)

The effect of information about the benefits and harms of mammography on women’s decision-making: study protocol for a randomized controlled trial
por: Carles, Misericòrdia, et al.
Publicado: (2017)

Dissociable Effects of Serotonin and Dopamine on the Valuation of Harm in Moral Decision Making
por: Crockett, Molly J., et al.
Publicado: (2015)

Evidence Synthesis for Decision Making 5: The Baseline Natural History Model
por: Dias, Sofia, et al.
Publicado: (2013)

Pharmacological and non-pharmacological interventions to influence adipose tissue function
por: Westerink, Jan, et al.
Publicado: (2011)

Model-free decision making is prioritized when learning to avoid harming others
por: Lockwood, Patricia L., et al.
Publicado: (2020)

Thyroid-stimulating hormone levels in the normal range and incident type 2 diabetes mellitus
por: de Vries, T. I., et al.
Publicado: (2018)

The relation between systemic inflammation and incident cancer in patients with stable cardiovascular disease: a cohort study
por: van’t Klooster, Cilie C, et al.
Publicado: (2019)

Shared decision making and antibiotic benefit-harm conversations: an observational study of consultations between general practitioners and patients with acute respiratory infections
por: Bakhit, Mina, et al.
Publicado: (2018)

Prediction of Lifetime and 10-Year Risk of Cancer in Individual Patients With Established Cardiovascular Disease
por: van ’t Klooster, Cilie C., et al.
Publicado: (2020)

Naive Decision Making: Mathematics Applied to the Social World
por: Körner, T W
Publicado: (2008)

Applied decision-making: applications in computer sciences and engineering
por: Sanchez, Mauricio A, et al.
Publicado: (2019)

Applying the Theory of Constructed Emotion to Police Decision Making
por: Fridman, Joseph, et al.
Publicado: (2019)

Decision consultations on preoperative radiotherapy for rectal cancer: large variation in benefits and harms that are addressed
por: Kunneman, M, et al.
Publicado: (2015)

Inconsistent allocations of harms versus benefits may exacerbate environmental inequality
por: Makov, Tamar, et al.
Publicado: (2020)

Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes
por: Sharif, Shahnam, et al.
Publicado: (2021)

Cost-benefit trade-offs in decision-making and learning
por: Sidarus, Nura, et al.
Publicado: (2019)

Interoceptive accuracy is associated with benefits in decision making in children
por: Pollatos, Olga, et al.
Publicado: (2023)

Comment on Vistisen et al. A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes. Diabetes Care 2021;44:901–907
por: Østergaard, Helena Bleken, et al.
Publicado: (2021)

Harm is all you need? Best interests and disputes about parental decision-making
por: Birchley, Giles
Publicado: (2016)

Risk assessment for the harmful effects of UVB radiation on the immunological resistance to infectious diseases.
por: Goettsch, W, et al.
Publicado: (1998)

Cancer immunotherapy: Benefit and harm?
por: Characiejus, Dainius
Publicado: (2012)

TRIOLOGY ACS: No benefit/No harm
por: Elmahdy, Mahmoud Farouk, et al.
Publicado: (2013)

Benefits and harms of mammography screening
por: Løberg, Magnus, et al.
Publicado: (2015)

The relation between body fat distribution, plasma concentrations of adipokines and the metabolic syndrome in patients with clinically manifest vascular disease
por: Schrover, Ilse M, et al.
Publicado: (2018)

What benefits and harms are important for a decision about cervical screening? A study of the perspective of different subgroups of women
por: van der Meij, Amber E, et al.
Publicado: (2019)

Cardiovascular risk and lifetime benefit from preventive treatment in type 2 diabetes: A post hoc analysis of the CAPTURE study
por: Østergaard, Helena Bleken, et al.
Publicado: (2022)

Ethical decision-making in biopharmaceutical research and development: applying values using the TRIP & TIPP model
por: Poplazarova, Tatjana, et al.
Publicado: (2020)

Perspectives on benefit-risk decision making: report of a colloquium
por: Press, National Academies
Publicado: (1972)

Baseline impulsivity may moderate L-DOPA effects on value-based decision-making
por: Petzold, Johannes, et al.
Publicado: (2019)

Baseline cardiovascular comorbidities, and the influence on cancer treatment decision-making in women with breast cancer
por: Subramaniam, Shridevi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6uci4nle2jpnuirc1l1fu1374t